Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.20
Delayed Data
As of 12:11pm ET
 -0.05 / -2.22%
Today’s Change
2.13
Today|||52-Week Range
8.90
-2.22%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close2.25
Today’s open2.30
Day’s range2.15 - 2.30
Volume249,100
Average volume (3 months)522,434
Market cap$119.1M
Dividend yield--
Data as of 12:11pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-41.40%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc-0.02-2.19%
ATHXAthersys Inc+0.01+0.35%
EGLTEgalet Corp-0.09-1.68%
SNDXSyndax Pharmaceutica...+0.04+0.55%
Data as of 12:26pm ET, 01/24/2017

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs